Cathal Friel
Founder at HVIVO PLC
Net worth: 13 M $ as of 2024-03-30
Profile
Cathal Martin Friel is the founder of Fastnet Equity Plc (founded in 2011) and Raglan Capital Ltd.
(founded in 2007).
He holds the title of Executive Chairman at Fastnet Equity Plc from 2011 to 2014 and was previously the Managing Director at Raglan Capital Ltd.
since 2007.
He was also the founder of Amryt Pharma Holdings Ltd.
(founded in 2015) and hVIVO PLC (founded in 2011), where he holds the title of Non-Executive Director and Non-Executive Chairman respectively.
Mr. Friel is also the founder of Poolbeg Pharma Plc and European Green Transition Plc.
Mr. Friel's current job(s) include being the Chief Executive Officer at Open Orphan DAC since 2019, the Non-Executive Chairman at hVIVO Ltd.
since 2020, and a Director at PrEP Biopharm Ltd.His former job(s) include being the Non-Executive Chairman at Venn Life Sciences Holdings Plc from 2018 to 2019, a Founding Director at Merrion Stockbrokers Ltd., and a Non-Executive Director at T5 Oil & Gas Ltd.
from 2013 to 2018.
Mr. Friel obtained an MBA from the University of Ulster in 1990.
Mr. Friel is also the founder of Poolbeg Pharma Plc, European Green Transition Plc.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
HVIVO PLC
3.11% | 2024-02-13 | 21,159,177 ( 3.11% ) | 8 M $ | 2024-03-30 |
POOLBEG PHARMA PLC
7.44% | 2024-02-18 | 37,219,757 ( 7.44% ) | 5 M $ | 2024-03-30 |
Cathal Friel active positions
Companies | Position | Start |
---|---|---|
HVIVO PLC | Founder | 2011-01-31 |
HVIVO PLC | Chairman | 2020-03-31 |
POOLBEG PHARMA PLC | Founder | - |
Raglan Capital Ltd.
Raglan Capital Ltd. Investment ManagersFinance Raglan Capital Ltd. is an Irish company that specializes in creating in-house companies for rapid listing on the London Stock Exchange. Raglan Capital aims to create one new company per year and achieve an IPO within three years. The private company has offices in Ireland, the UK, and the US. The company's portfolio includes companies such as Poolbeg Pharma, HVIVO, Amryt Pharma, Fastnet Oil & Gas, and European Green Metals. The company was founded in 2007 by Cathal Martin Friel, who has been the CEO since incorporation. | Chief Executive Officer | 2006-12-31 |
Open Orphan DAC
Open Orphan DAC Packaged SoftwareTechnology Services Open Orphan DAC develops platform for pharmaceutical and biotechnology companies seeking to commercialize their products across Europe. It focuses on building its database of over 500 pharmaceutical companies with orphan drugs either approved or advancing through clinical trials. The company is headquartered in Ballsbridge, Ireland. | Chief Executive Officer | 2019-05-09 |
PrEP Biopharm Ltd.
PrEP Biopharm Ltd. Pharmaceuticals: MajorHealth Technology PrEP Biopharm Ltd. develops and manufactures biopharmaceutical products. The British company was founded in 2015 by Ryan Muldoon and Bruce A. Malcolm. Ryan Muldoon has been the CEO since 2015. | Director/Board Member | 2020-07-09 |
Former positions of Cathal Friel
Companies | Position | End |
---|---|---|
T5 Oil & Gas Ltd.
T5 Oil & Gas Ltd. Oil & Gas ProductionEnergy Minerals T5 Oil & Gas Ltd. explores oil and gas resources. The firm develops portfolio of conventional oil and gas resources. The company was incorporated by Patrick Joseph Plunkett, Gerry Sheehan, Matthew O'Donoghue, Andrew Guy Windham and Stephen James McTiernan on August 07, 2013 and is headquartered in London, the United Kingdom. | Director/Board Member | 2018-08-08 |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Founder | 2017-03-27 |
Merrion Stockbrokers Ltd.
Merrion Stockbrokers Ltd. Investment Banks/BrokersFinance Part of Cantor Fitzgerald LP, Merrion Stockbrokers Ltd. is a brokerage firm that provides brokerage services. The private company is based in Dublin, Ireland. The Irish company was founded in 1999. Johnny Lynch has been the CEO of the company since 2015. | Director/Board Member | - |
░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░ | - |
Training of Cathal Friel
University of Ulster | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
HVIVO PLC | Commercial Services |
POOLBEG PHARMA PLC | Health Technology |
Private companies | 9 |
---|---|
hVIVO Ltd.
hVIVO Ltd. Miscellaneous Commercial ServicesCommercial Services hVIVO Ltd. engages in the provision of clinical development services with a focus on human disease models. It specializes in human challenge studies using influenza, human rhinovirus, and respiratory syncytial virus for pharmaceutical and biotech companies. The company was founded by John Sidney Oxford in 1989 and is headquartered in London, the United Kingdom. | Commercial Services |
Merrion Stockbrokers Ltd.
Merrion Stockbrokers Ltd. Investment Banks/BrokersFinance Part of Cantor Fitzgerald LP, Merrion Stockbrokers Ltd. is a brokerage firm that provides brokerage services. The private company is based in Dublin, Ireland. The Irish company was founded in 1999. Johnny Lynch has been the CEO of the company since 2015. | Finance |
Fastnet Equity Plc
Fastnet Equity Plc Financial ConglomeratesFinance Fastnet Equity Plc engages in exploration of oil and gas. It operates through the following geographical segments: UK and Ireland; and Morocco. The company was founded in December 20, 2004 and is headquartered in Stockport, the United Kingdom. | Finance |
Raglan Capital Ltd.
Raglan Capital Ltd. Investment ManagersFinance Raglan Capital Ltd. is an Irish company that specializes in creating in-house companies for rapid listing on the London Stock Exchange. Raglan Capital aims to create one new company per year and achieve an IPO within three years. The private company has offices in Ireland, the UK, and the US. The company's portfolio includes companies such as Poolbeg Pharma, HVIVO, Amryt Pharma, Fastnet Oil & Gas, and European Green Metals. The company was founded in 2007 by Cathal Martin Friel, who has been the CEO since incorporation. | Finance |
Venn Life Sciences Holdings Plc
Venn Life Sciences Holdings Plc Services to the Health IndustryHealth Services Venn Life Sciences Holdings Plc is a clinical research organization, which provides a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations. Its services include drug development planning and strategy, early drug development, clinical monitoring, medical monitoring, investigator initiated studies, clinical feasibility assessment, regulatory affairs and consulting, quality assurance, and drug development training and courses. The company was founded on February 2, 2011 and is headquartered in Dublin, Ireland. | Health Services |
T5 Oil & Gas Ltd.
T5 Oil & Gas Ltd. Oil & Gas ProductionEnergy Minerals T5 Oil & Gas Ltd. explores oil and gas resources. The firm develops portfolio of conventional oil and gas resources. The company was incorporated by Patrick Joseph Plunkett, Gerry Sheehan, Matthew O'Donoghue, Andrew Guy Windham and Stephen James McTiernan on August 07, 2013 and is headquartered in London, the United Kingdom. | Energy Minerals |
PrEP Biopharm Ltd.
PrEP Biopharm Ltd. Pharmaceuticals: MajorHealth Technology PrEP Biopharm Ltd. develops and manufactures biopharmaceutical products. The British company was founded in 2015 by Ryan Muldoon and Bruce A. Malcolm. Ryan Muldoon has been the CEO since 2015. | Health Technology |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Open Orphan DAC
Open Orphan DAC Packaged SoftwareTechnology Services Open Orphan DAC develops platform for pharmaceutical and biotechnology companies seeking to commercialize their products across Europe. It focuses on building its database of over 500 pharmaceutical companies with orphan drugs either approved or advancing through clinical trials. The company is headquartered in Ballsbridge, Ireland. | Technology Services |
- Stock Market
- Insiders
- Cathal Friel